Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Weloline
Weloline is a long-acting bronchodilator that contains Theophylline 400 mg, designed to improve lung function and ease breathing in patients with chronic respiratory conditions. It is commonly used in the treatment of asthma, COPD, and other obstructive airway diseases. The extended-release formulation of Weloline ensures steady and sustained therapeutic effects, providing round-the-clock symptom relief and enhancing overall pulmonary function.
Uses of Weloline
Weloline is indicated for:
Chronic Asthma Management
Chronic Obstructive Pulmonary Disease (COPD)
Emphysema
Long-term Bronchodilation for Maintenance of Airway Function
Benefits of Weloline
Extended-Release Formulation for Continuous Bronchodilation
Improves Breathing and Reduces Wheezing
Helps Prevent Asthma Attacks and COPD Exacerbations
Reduces Shortness of Breath and Coughing
Fewer Dosing Intervals, Convenient for Daily Use
Enhanced Lung Function for Better Quality of Life
Mechanism of Action of Weloline
Theophylline works by inhibiting phosphodiesterase enzymes, leading to an increase in cAMP (cyclic adenosine monophosphate) levels. This results in relaxation of smooth muscles in the airways, thereby dilating the bronchi and improving airflow. Additionally, Theophylline has anti-inflammatory properties that help reduce inflammation in the respiratory tract, further aiding in the management of chronic lung conditions.